GlaxoSmithKline PLC

Healthcare · Drug Manufacturers - General

50.50$ +0.3% vs. previous close Closing price · As of: Aug 13, 2026

Statements

Balance Sheet

GlaxoSmithKline PLC (GSK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 61,365 million GBP. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of GBP.

Tick rows to compare them in a chart (up to 4)

Balance Sheet GSK
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	58,787	59,081	59,235	58,233	58,783	56,381	56,159	57,635	58,604	58,066	62,365	63,632	83,245	105,572	104,629	104,581	104,622	109,945	107,726	106,387	106,100	107,141	79,191	108,141	67,327	60,146	72,451	75,596	74,285	75,220	73,914	73,401	58,049	59,463	78,355	81,204	82,578	61,011	82,905	61,365
Current Assets	17,612	16,711	16,787	16,426	17,656	15,907	16,423	17,044	17,418	16,927	17,524	18,228	20,990	25,821	27,307	28,392	25,702	27,677	25,558	24,267	24,613	25,293	27,346	65,809	22,604	20,769	24,382	24,598	25,924	23,767	21,734	21,191	17,298	16,997	23,343	24,218	24,020	17,479	23,421	17,453
Cash	4,614	4,897	4,509	3,986	4,743	3,833	4,004	4,046	3,793	3,874	4,132	4,123	4,305	6,236	5,913	10,090	5,537	8,601	6,563	4,839	4,656	5,789	4,902	7,851	4,025	3,723	3,573	3,992	3,878	3,743	3,524	3,744	3,192	3,693	5,762	4,932	4,437	3,391	4,539	3,086
Cash & Short-Term Investments	4,699	5,175	4,597	4,071	4,825	3,974	4,080	4,127	3,873	3,958	4,213	4,207	4,391	6,340	6,020	10,197	5,644	8,707	6,646	4,921	4,738	5,872	10,371	7,933	7,994	7,877	8,624	8,269	8,157	6,606	5,173	3,771	3,212	3,714	5,789	4,959	4,451	3,400	4,540	3,087
Receivables	7,100	5,691	6,224	6,196	6,491	4,672	6,106	6,559	7,292	25,644	6,551	6,875	8,173	9,469	11,029	9,262	10,887	9,930	9,910	10,371	11,170	10,878	9,820	8,343	9,035	6,218	8,815	9,020	10,831	9,437	9,210	9,832	7,383	5,999	9,682	10,548	11,179	7,745	10,467	8,025
Inventory	5,373	5,102	5,417	5,743	5,661	5,557	5,659	5,943	5,788	5,476	5,678	5,959	6,776	7,878	7,380	7,903	8,326	8,196	8,576	8,745	8,419	7,833	6,775	5,664	5,201	5,146	6,621	7,008	6,689	7,009	7,203	7,406	5,918	5,669	7,745	8,321	8,236	5,914	8,119	6,244
Property, Plant & Equipment	14,279	13,334	13,555	13,855	14,250	14,692	14,973	14,224	14,247	47,692	11,292	11,408	11,700	11,314	11,402	11,431	11,205	11,006	10,633	10,589	10,667	10,672	10,704	9,153	9,650	9,620	9,414	9,315	9,454	–	–	–	9,725	10,073	9,971	9,918	10,132	10,048	–	–
Goodwill	5,865	5,965	5,960	5,864	5,764	5,734	5,601	5,778	5,848	5,789	6,807	7,026	11,046	13,992	13,514	13,589	14,076	14,486	14,407	14,415	14,268	14,292	9,277	7,173	8,032	7,046	8,478	8,538	8,511	8,683	8,815	8,798	6,680	6,982	8,940	9,228	9,581	7,006	9,609	7,336
Intangible Assets	18,471	18,776	18,753	18,465	17,921	17,562	17,290	17,294	17,263	17,202	20,022	20,134	32,455	41,008	39,057	38,629	39,642	40,768	40,588	40,522	40,775	40,741	18,852	13,810	17,402	14,318	17,508	19,745	18,668	18,826	19,791	19,559	15,010	15,515	20,985	21,071	22,705	16,719	23,919	16,701
Total Liabilities	54,789	54,118	53,642	53,809	53,954	52,892	52,569	54,612	54,881	54,394	58,994	60,665	65,185	81,254	79,710	79,700	77,958	81,502	78,738	76,578	76,776	78,234	65,898	80,646	57,598	50,050	58,464	60,137	58,883	58,909	57,202	55,995	44,596	46,377	60,731	61,534	61,371	45,016	59,931	44,292
Current Liabilities	18,137	19,001	18,757	28,788	27,438	26,569	26,927	18,198	18,395	22,491	24,460	25,779	25,514	31,860	31,414	29,560	28,673	30,275	27,973	29,545	30,226	32,060	30,033	45,949	23,390	22,810	25,590	28,107	27,328	26,857	25,070	25,718	21,459	21,697	26,888	27,925	28,721	21,353	29,577	21,404
Short-Term Debt	3,961	4,129	3,740	6,612	4,740	2,825	3,442	3,470	2,902	5,793	8,413	10,147	8,216	9,165	9,008	7,369	6,353	5,092	4,376	6,964	6,565	4,877	5,203	4,040	3,118	3,952	5,269	7,528	5,911	3,586	3,305	4,255	2,815	2,349	2,527	2,809	3,845	3,007	6,652	4,265
Accounts Payable	9,063	3,596	9,414	17,392	19,840	3,528	21,088	10,475	11,002	14,037	11,241	11,715	12,970	5,490	18,984	19,090	19,576	5,956	20,157	19,709	20,535	6,142	21,413	17,981	17,989	3,866	17,642	17,737	19,019	20,198	18,470	18,007	14,375	3,462	19,554	20,309	15,675	15,354	18,904	14,255
Long-Term Debt	20,044	18,087	18,304	15,931	19,157	19,298	19,684	32,320	32,357	87,237	23,344	23,313	24,833	23,590	24,741	25,726	23,334	23,425	23,047	20,442	20,736	20,572	29,226	18,784	19,322	17,035	16,644	15,553	15,993	14,154	–	–	13,244	13,703	16,474	15,304	14,894	14,708	–	–
Shareholders' Equity	138	1,124	1,714	811	1,294	-68	-69	3,679	4,476	4,360	4,014	3,614	11,772	15,109	16,236	16,796	18,469	19,940	20,509	21,243	20,800	20,391	13,954	19,885	10,216	10,598	14,615	16,135	16,029	17,015	17,483	18,168	14,008	13,671	18,273	20,269	21,739	16,348	23,541	17,538
Retained Earnings	-6,550	-5,392	-4,906	-5,854	-5,349	-6,477	-6,353	-2,680	-2,081	-2,137	-2,438	-2,804	5,265	8,451	7,877	8,182	9,121	11,761	9,244	10,194	10,494	13,264	5,745	11,931	2,893	4,363	6,992	8,160	8,565	9,228	10,024	10,850	8,187	7,796	10,722	12,055	13,484	10,191	15,284	11,395
Shares Outstanding	1,961	1,966	1,967	1,955	1,974	1,956	1,978	1,984	1,989	1,991	1,991	1,996	2,003	2,009	2,004	2,009	2,016	2,017	2,015	2,019	2,027	2,038	2,033	2,032	2,044	2,046	2,043	2,047	2,056	2,059	2,057	2,061	2,040	2,073	2,069	2,055	2,051	2,043	2,037	2,031

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings